Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:2168-2174, doi:10.1016/j.jacc.2009.02.045
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Franceschi, F.
Right arrow Articles by Deharo, J.-C.
PubMed
Right arrow Articles by Franceschi, F.
Right arrow Articles by Deharo, J.-C.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART RHYTHM DISORDERS

Incidence, Risk Factors, and Outcome of Traumatic Tricuspid Regurgitation After Percutaneous Ventricular Lead Removal

Frédéric Franceschi, MD*, Franck Thuny, MD*, Roch Giorgi, MD, PhD{dagger}, Islem Sanaa, MD*, Eric Peyrouse, MD*, Xavier Assouan, MD*, Sébastien Prévôt, MD*, Emilie Bastard, MD*, Gilbert Habib, MD* and Jean-Claude Deharo, MD*,*

* Cardiology Department, University Hospital La Timone, Marseilles, France
{dagger} Epidemiology and Biostatistics Department, University Hospital La Timone, Marseilles, France

Manuscript received December 2, 2008; revised manuscript received February 23, 2009, accepted February 24, 2009.

* Reprint requests and correspondence: Dr. Jean-Claude Deharo, CHU La Timone Adultes, Cardiologie 9ème étage, 264 Rue Saint Pierre, 13385 Marseille Cédex 5, France (Email: jean-claude.deharo{at}ap-hm.fr).

Objectives: This study sought to evaluate the incidence, risk factors, and outcome of traumatic tricuspid regurgitation (TTR) induced by percutaneous removal of chronically implanted transvenous leads.

Background: Although lead removal using modern tools has been shown to be highly effective and safe, TTR has not been systematically evaluated.

Methods: All patients undergoing ventricular lead removal at our center were studied. Lead removal was performed by simple traction, laser sheath, and/or lasso technique. Presence of a new TTR after removal was assessed by transthoracic echocardiography. Pre-defined clinical and technical parameters were studied for their association with TTR. Patients were followed up by outpatient visits.

Results: We removed 237 ventricular leads in 208 patients. Median time from lead implantation was 46.4 months (range 0.7 to 260.5 months). A TTR occurred in 19 patients (9.1%), severe in 14. Three independent risk factors of TTR were found: use of laser sheath (p = 0.004), use of both laser sheath and lasso (p = 0.02), and female sex (p = 0.02). After a follow-up of 4,130 person-months (median 17.9 months), 5 TTR patients were medically treated for new right-sided heart failure symptoms, 2 had undergone surgical repair of the tricuspid valve, and 6 had died (2 from heart failure and 4 from noncardiac causes). Right-sided heart failure occurred only in patients with severe TTR.

Conclusions: This study found that TTR is not uncommon after percutaneous lead removal. It is strongly associated with the use of additional tools beyond simple traction and also with female sex. In the long term, right-sided heart failure is frequent in patients with severe TTR.

Key Words: percutaneous lead removal • complication • traumatic tricuspid regurgitation • flail leaflet

Abbreviations and Acronyms
  CI = confidence interval
  HR = hazard ratio
  ICD = implantable cardioverter-defibrillator
  OR = odds ratio
  TEE = transesophageal echocardiography
  TR = tricuspid regurgitation
  TTE = transthoracic echocardiography
  TTR = traumatic tricuspid regurgitation


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A24. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement